Decoding the End Points of Poly (ADP-ribose) Polymerase Inhibitor Trials in Ovarian Cancer
B
Bradley J. Monk
R
Robert L. Coleman
(Texas Oncology, US Oncology Network, The Woodlands, TX)
D
David M. O'Malley
(GOG Foundation and The Ohio State University and The James Comprehensive Cancer Center, Columbus, OH)
K
Kathleen N. Moore
(Division of Gynecologic Oncology Stephenson Cancer Center University of Oklahoma Oklahoma City Oklahoma USA)
A
Antonio González-Martín
(Cancer Center Clinica Universidad de Navarra, Madrid, Spain)
T
Thomas J. Herzog
(GOG Foundation and University of Cincinnati Cancer Center, Cincinnati, OH)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 43, Issue 36
Published
December 20, 2025
Pages
3846-3847
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (6)
B
Bradley J. Monk
R
Robert L. Coleman
Texas Oncology, US Oncology Network, The Woodlands, TX
D
David M. O'Malley
GOG Foundation and The Ohio State University and The James Comprehensive Cancer Center, Columbus, OH
K
Kathleen N. Moore
Division of Gynecologic Oncology Stephenson Cancer Center University of Oklahoma Oklahoma City Oklahoma USA
A
Antonio González-Martín
Cancer Center Clinica Universidad de Navarra, Madrid, Spain
T
Thomas J. Herzog
GOG Foundation and University of Cincinnati Cancer Center, Cincinnati, OH
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001